Cognitive changes associated with chemotherapy in breast cancer: an assessment of social cognition and executive functions in Peruvian patients
Chemotherapy was associated with measurable cognitive decline in a subset of Peruvian breast cancer patients. Brief and culturally adaptable tools such as the FER test offer a promising approach for routine cognitive screening in oncology settings, particularly in resource-limited contexts. Incorporating these assessments into standard care may facilitate early detection and more personalized supportive interventions.
Authors
- Jorge Honles (ORCID: https://orcid.org/0000-0003-3015-5321)
- Sandro A. Casavilca-Zambrano
- Stéphane Bertani (ORCID: https://orcid.org/0000-0002-0398-9745)
- Valentina A. Zavala (ORCID: https://orcid.org/0000-0003-2040-1760)
- Tatiana Vidaurre
- Laura Fejerman
- Ruddy Liendo-Picoaga
- Juan José Contreras Mancilla
- Nilton Custodio
- Rosa Montesinos
- Jenny Katherine Bonifacio Mundaca
Institutions
- Institut de Recherche pour le Développement (BJ)
- Université Toulouse III - Paul Sabatier (FR)
- Universidad Científica del Sur (PE)
- Institute for Anthropological Research (HR)
- Universidad de Huánuco (PE)
- Instituto Nacional de Enfermedades Neoplásicas (PE)
- Institute of Peruvian Studies (PE)
- Pharmacochimie et Biologie pour le Développement (FR)
- Institut de Recherche pour le Développement (FR)
- University of California, Davis (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1093/oncolo/oyag058
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00